Table 1.
Characteristics and comorbidities of patients with COVID-19.
| Age | 21–90 years (median: 63 years) |
| Sex | 58 M; 25 F (M:F = 2.3) |
| Comorbidity with increased risk for severe COVID-19a | 65/80 (81.3%) |
| Obesity (30≤ BMI <40) | 21 (26.3%) |
| Morbid obesity (BMI ≥ 40) | 16 (20.0%) |
| <50years | 7/16 (43.8%) |
| ≥50 years | 9/64 (14.1%) |
| Type 2 diabetes mellitus | 22 (27.5%) |
| Serious cardiovascular disease | 18 (22.5%) |
| Malignancies | 10 (12.5%) |
| Chronic obstructive pulmonary disease (COPD) | 6 (7.5%) |
| Chronic kidney disease | 6 (7.5%) |
| Solid organ transplant | 4 (5.0%) |
| Comorbidity with possible increased risk for severe COVID-19∗∗ | 7/80 (8.8%) |
| Hypertension | 6 |
| Immunocompromised state | 3 |
| Liver disease | 1 |
| No significant comorbidity | 7/80 (8.8%) |
| Coinfection with other respiratory virus | 3/83 (3.6%) |
| Influenza B | 1 |
| Human Rhinovirus | 1 |
| Human coronavirus | 1 |
a
The underlying medical conditions with increased risk or possible increased risk for severe illness from COVID-19 for people of any age group are based on CDC publications (https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html).